1 November 2018 in Journal of Chemical Technology & Biotechnology
BACKGROUND: Chemically defined media (CDM) are used routinely in industrial settings for the production of biopharmaceuticals from mammalian cells, so attention has shifted to understanding their chemical behavior and impact on process robustness. In this context, one particular problem is the risk of cross reactivity and instability in complex mixtures of chemicals at high concentrations.RESULTS: In order to characterize potentially unstable medium compounds in feed media, we developed and validated a novel liquid chromatography tandem mass spectrometry (LC‐MS/MS) method to simultaneously quantify the majority of medium compounds. We used this application advantage to provide the following insights into molecular processes occurring in CDM prepared at different temperatures and during storage: Concentration profiles of critical compounds in CDM are independent of preparation temperature and storage material but show significant alterations over time. In particular l‐cysteine, l‐proline, vitamin B6, thiamine and cyanocobalamin were found to be rather unstable. Using mixed mode chromatography allows expansion of the method to cover additional analytes of interest, as demonstrated by inclusion of seven additional CDM reaction products.CONCLUSION: The successful development of a new LC‐MS/MS method allowed us to show the impact of storage duration on the stability of CDM compounds. Furthermore, the results suggest that essential parameters for medium preparation (e.g. temperature) and storage upscaling (e.g. vessel material) are not impacting upon the chemical composition of CDM. © 2018 The Authors. Journal of Chemical Technology & Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
14 June 2025 in European Journal of Pharmaceutics and Biopharmaceutics
Understanding the relationship between structure and function is crucial in drug development. Recombinant proteins present unique challenges when establishing structure-function relationships (SFR) due to the extensive options for potential modifications across numerous residues. Even simple stress studies lack degradation selectivity as they lead to multiple, simultaneous modifications. Co-occurring modifications at amino acid residues make direct correlations with a specific stressor and resolving the causal impact on functionality difficult. The introduction of more variance into the data set would reduce the correlation structure. In this study, we demonstrate the feasibility and benefits of a multifactorial design approach for SFR establishment. Design of experiments (DoE) allows for the parallel investigation of stress factors via combined experiments, resulting in a higher variance of stress conditions and consequently a broader variation in degradation. This approach enables a more insightful correlation analysis along with model-based data evaluation strategies, thereby facilitating significantly improved data interpretation results during SFR studies.
19 May 2026 in International Journal of Biological Macromolecules
A robust understanding of structure-function relationships (SFRs) is fundamental for tailored and robust chemistry, manufacturing, and control (CMC) activities. Yet, conventional forced degradation studies (FDS) often employ a one-factor-at-a-time (OFAT) methodology, which commonly leads to correlated modifications and therefore limited reliability of SFR determination missing statistical certainty. By applying a forced-degradation-study design of experiments (FDS-DoE) framework to trastuzumab, methodological advantages are underscored, including improved data interpretation and consistency with literature findings, while adding deeper insights to the antibodies SFRs. As the choice of stress conditions in the design of FDS studies is critically important to establish meaningful SFRs, we present a detailed experimental comparison of harsh vs. moderate CMC development relevant stress conditions applying the FDS-DoE workflow. While harsh conditions mainly reflect typical FDS protocols and test the boundaries of a molecule's resilience, the moderate conditions were designed to simulate CMC-relevant environments better. Furthermore, we introduce a critical quality attribute (CQA) assessment framework that uses partial least square regression to systematically categorize modifications according to their statistical significance (via permutation testing) and predicted potency loss. The combination of multifactorial FDS-DoE with this CQA assessment framework increased statistical power over traditional OFAT methods, establishing a predictive, automated and scalable strategy for identifying relevant SFRs and CQAs, a capability especially advantageous for macromolecules in biopharmaceutical development.